Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
19 February 2015
Header
Header image
Highlight of the week

News

New Landmark in fight against counterfeit medicines with establishment of the European Medicines Verification System
19 February 2015

(19 February - Brussels): Major European healthcare stakeholders have taken a significant step towards securing the legitimate pharmaceutical supply chain against the risk of falsified [...] Read more

From our blog

From our blog

European Healthcare Stakeholders Announce Breakthrough In Medicines Verification System
19 February 2015 by François Bouvy

Health care stakeholders have achieved an important goal in securing the legitimate pharmaceutical supply chain in line with the requirement of the Falsified Medicines Directive, with the establishment of the European Medicines Verification Organisation.

Read more

Events calendar

Events Calendar

MEP Awards 2015
On 18/03/2015 (Brussels)

Now in their 11th year, the Parliament Magazine's annual MEP awards bring together Members of the European Parliament and EU stakeholders to celebrate the work and highlight the outstanding achievements of both new and returning MEPs.

To meet the MEP Health Awards shortlisted candidates, click here.

Read more

What we are reading

What we are reading

NICE 'sets price too high for NHS medicines'
19 February 2015 (BBC)

The price the NHS in England agrees to pay for new medicines is too high, causing more harm than good overall, an analysis suggests.

Read more

What we are reading

EU-US trade: hopes and fears
19 February 2015 (Euronews)

Euronews report featuring Richard Bergstrom, Director-General of EFPIA, talking about TTIP from the perspective of the pharma industry.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail